BOSTON — Some concerns about whether reprogrammed stem cells are acceptable stand-ins for embryonic stem cells in biomedical research may be laid to rest by a new study.
Previously, scientists have found that gene activity, such as how genes turn on and off, differs between induced pluripotent stem cells, or iPS cells, and embryonic stem cells, the flexible cells that iPS cells are designed to mimic.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.